Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5888507 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL8382426 | 0.74 | CTSD (0.32) | — | |
| Hydrochloric Acid SCHEMBL8846157 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL8155036 | 0.74 | — | — | |
| SCHEMBL28265464 | 0.72 | CTSD (0.32) | — | |
| SCHEMBL8853537 | 0.70 | CTSD (0.31) | — | |
| SCHEMBL27894201 | 0.70 | CTSD (0.31) | — | |
| SCHEMBL1097825 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL8383999 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL8846337 | 0.68 | CTSD (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419963-B2 | Diels-Alder conjugation methods | REGENERON PHARMACEUTICALS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20240207412-A1 | DIELS-ALDER CONJUGATION METHODS | REGENERON PHARMACEUTICALS, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| US-11701427-B2 | Diels-alder conjugation methods | REGENERON PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| CN-115968304-A | Diels-Alder conjugation methods | 瑞泽恩制药公司 | 2023-04-14 | — | — | CN | disclosed |
| EP-4135775-A1 | DIELS-ALDER CONJUGATION METHODS | Regeneron Pharmaceuticals, Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| US-20220378918-A1 | DIELS-ALDER CONJUGATION METHODS | REGENERON PHARMACEUTICALS INC. (US) | 2022-12-01 | — | — | US | disclosed |
| WO-2021211984-A1 | DIELS-ALDER CONJUGATION METHODS | REGENERON PHARMACEUTICALS, INC. (US) | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207412-A1 | DIELS-ALDER CONJUGATION METHODS | GLUL, TGM2, GLS | CYP1A2 1978/4885CYP2A6 2302/4885TAAR1 3571/4885 |
| US-11701427-B2 | Diels-alder conjugation methods | GLUL, TGM2, GLS | CYP1A2 1978/4885CYP2A6 2302/4885TAAR1 3571/4885 |
| US-20220378918-A1 | DIELS-ALDER CONJUGATION METHODS | GLUL, TGM2, GLS | CYP1A2 1978/4885CYP2A6 2302/4885TAAR1 3571/4885 |
| US-12419963-B2 | Diels-Alder conjugation methods | GLUL, TGM2, GLS | CYP1A2 1978/4885CYP2A6 2302/4885TAAR1 3571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.